[1]
N. Loman, H. Saghir, and S. Kimbung, “Predicting neoadjuvant chemotherapy treatment response in hormone- receptor-positive/HER2-negative breast cancer – results from the Swedish SCAN-B population-based cohort”, AO, vol. 64, pp. 1577–1589, Nov. 2025.